TO

Tuyen Ong

CEO at Ring Therapeutics

Cambridge, Massachusetts

Overview 

Tuyen Ong is the Chief Executive Officer at Ring Therapeutics and CEO Partner at Flagship Pioneering, with a background in gene therapy and biotechnology. Notable highlights from their career include serving as SVP and Head of Ophthalmology Franchise at Biogen and Chief Medical Officer at PTC Therapeutics, Inc.

Work Experience 

  • Chief Executive Officer

    2020 - Current

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

Raised $253,500,000.00 from Altitude Life Science Ventures, Flagship Pioneering, UPMC Enterprises, CJ Investment, Partners Investment, T. Rowe Price, Alexandria Venture Investments, Invus and Kyowa Kirin.

  • CEO partner

    2020

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

  • Member Board of Directors

    2022

Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.

Raised $100,000,000.00 from Forbion Capital Partners, Longwood Fund, Omega Funds and Atlas Venture.

  • Board of Advisors

    2017

Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space.

Raised $135,000,000.00 from Novaquest Capital Management.

  • Board of Directors

    2020 - 2022

  • SVP, Head of Ophthalmology Franchise

    2019 - 2020

Biogen is a biotechnology company engaged in the development of innovative therapies for neurological and neurodegenerative diseases.

  • EVP, Chief Development Officer

    2017 - 2019

    Nightstar Therapeutics (Acquired by Biogen in June 2019)

  • Chief Medical Officer

    2014 - 2017

    SVP, Head of Clinical and Research Development (2014-2016)

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

Raised $1,568,049,151.00 from Blackstone Life Sciences and Blackstone Credit.

  • VP, Clinical Development and Operations

    2010 - 2014

    Executive Director, Head of Clinical and Scientific Affairs (2010 -2013)

Bausch & Lomb is an eye health company bringing visionary Ideas to Eye Health.

Raised $1,400,000,000.00 from JP Morgan.

  • Global Clinical Lead

    2005 - 2010

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Raised $32,000,000,000.00 from Starboard Value.

Articles About Tuyen

Relevant Websites